Entasis Therapeutics Inc, based in Waltham, MA, is a leading biopharmaceutical company focused on developing and delivering innovative therapies for patients in critical care and infectious disease. With a global mission to address urgent needs and advance treatment options in areas of high unmet need, they offer innovative solutions for patients with serious, life-threatening conditions and therapies for emerging illnesses caused by drug-resistant microorganisms.
As a subsidiary of Innoviva, Inc, Entasis Therapeutics Inc is a growing and diversified company that blends rigorous medical science with the latest advances in pharmaceutical innovation. Led by a mission-driven team, they are dedicated to delivering products that save lives and making a lasting impact in the field of healthcare.
Generated from the website